Moby summary of Sabre Corporation's Q2 2026 earnings call
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
While the top- and bottom-line numbers for Atlassian (TEAM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Moby summary of Genie Energy Ltd.'s Q2 2026 earnings call
Moby summary of Commerce.com, Inc.'s Q2 2026 earnings call
Moby summary of Zoetis Inc.'s Q2 2026 earnings call
Moby summary of Ducommun Incorporated's Q2 2026 earnings call
Moby summary of Immunovant, Inc.'s Q1 2027 earnings call
Moby summary of D-Wave Quantum Inc.'s Q2 2026 earnings call
Texas Roadhouse (TXRH) delivered earnings and revenue surprises of -2.63% and +0.29%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Atlassian (TEAM) delivered earnings and revenue surprises of +26.35% and +6.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
(Bloomberg) -- Jane Street is negotiating with a group of investors in a private-credit deal that would rework the firm’s $11 billion debt load and limit its financial disclosures to market participants, according to people with knowledge of the matter.Most Read from BloombergIran Says Agreement on Hormuz Shipping Reached With OmanGoogle AI Veterans Depart During Seismic Leadership ShiftWhy Do Data Centers Use So Much Fresh Water?Ishbia’s Mortgage Firm Suffers Record Drop on Dividend HaltTrump M
ARK Makes Bold $23 Million SpaceX Bet Despite Post-Earnings Drop
Advanced Micro Devices said on Thursday it would buy chip startup Taalas for an undisclosed amount, strengthening its technology as it taps into the rapidly growing market for AI inference workloads. Toronto-based Taalas develops specialized silicon designed to reduce computing and memory bottlenecks in AI inference, the process of running trained AI models to generate responses or predictions. Specialized inference chips have become a critical focus for semiconductor makers as AI shifts from training to real-time, high-volume deployment, and companies race to cut computing costs.
A fragile breakthrough could reshape inflation and rate expectations
Moby summary of Celsius Holdings, Inc.'s Q2 2026 earnings call
MARA’s bitcoin holdings drove a $611 million quarterly loss, while new sites and bitcoin-backed borrowing advanced its planned expansion into AI infrastructure.
Moby summary of Townsquare Media, Inc.'s Q2 2026 earnings call
Moby summary of Bentley Systems, Incorporated's Q2 2026 earnings call
Moby summary of Cars.com Inc.'s Q2 2026 earnings call
Moby summary of LifeStance Health Group, Inc.'s Q2 2026 earnings call
MACOM Technology Solutions (NASDAQ:MTSI) reported record fiscal third-quarter results, citing strong demand across its data center, industrial and defense, and telecom markets. The company also issued fourth-quarter guidance that calls for another sequential increase in revenue, margins and adjusted
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported a wider second-quarter loss as revenue declined sharply from the prior-year period, while the company highlighted completed enrollment in its Phase III SONATA-HCM trial and outlined plans to resubmit a new drug application for ZYNQUISTA in type 1 diabet
MKS (NASDAQ:MKSI) reported second-quarter 2026 revenue of $1.25 billion, up 16% sequentially and 28% from a year earlier, as demand increased across semiconductor, electronics and packaging, and specialty industrial markets. Management said revenue and key profitability measures reached the high end
Lightbridge (NASDAQ:LTBR) reported progress in its nuclear fuel development program during the second quarter and first half of 2026, including the removal of its first irradiated fuel material samples from Idaho National Laboratory’s Advanced Test Reactor and steps toward commercial-scale fabricati
Ligand Pharmaceuticals (NASDAQ:LGND) reported second-quarter 2026 results marked by higher royalty revenue and adjusted earnings, while highlighting the post-quarter close of its XOMA Royalty acquisition and a $700 million zero-coupon convertible-note offering. Total revenue rose 34% year over year
Dow Jones futures: The market pauses, but what happens next? Don't buy these AI stocks yet. Cloudflare, Sezzle lead big earnings movers late.
Moby summary of Targa Resources Corp.'s Q2 2026 earnings call
Moby summary of Arhaus, Inc.'s Q2 2026 earnings call